InvestLog
← Back to Research← 返回研究
TAKEarnings ReleaseSource checkedAugust 3, 2026by InvestLog AI

TAK earnings release — EPS beat +33.2% · revenue beat +7.4%Takeda Pharmaceutical Co., Ltd. (TAK) 财报发布 — EPS 高于预期+33.2% · 营收 高于预期+7.4%

Key Results

Takeda Pharmaceutical Company Limited (TAK) published results at 2026-07-30 02:37:00.

Actual vs Consensus

  • EPS: $0.23 vs $0.17 estimate, beat+33.2%.
  • Revenue: $7.7B vs $7.1B estimate, beat+7.4%.

    • Official release: Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track

    核心结果

    Takeda Pharmaceutical Co., Ltd. (TAK) 已发布财报，发布时间：2026-07-30 02:37:00。

    实际值与市场预期

  • EPS：$0.23 vs $0.17 预期，高于预期+33.2%。
  • 营收：$7.7B vs $7.1B 预期，高于预期+7.4%。

    • 官方公告：Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track

    View TAK stock details ->查看 TAK 个股详情 ->

    This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。